Email bulletins

Archive

February 2021

  • Hepatitis C does not raise the risk of death from COVID-19
  • COVID-19 slows viral hepatitis elimination, global survey finds
  • COVID-19 hits viral hepatitis care for vulnerable populations
  • Hepatitis C treatment reduces stroke and heart attack risk
  • Hepatitis C declining among drug users in UK
  • High adherence and hepatitis C cure rates in active drug and alcohol users
  • WHA releases new messaging guide for global fund advocates
  • Is this your copy of the infohep news bulletin?

January 2021

  • Will people with liver disease be prioritised for COVID-19 vaccination?
  • Questions about COVID-19 vaccination for people with liver disease: guidance from patient associations and health bodies
  • Public-sector hepatitis C treatment programmes expanding in lower- and middle-income countries
  • What's needed to eliminate hepatitis C in people with HIV in Scotland?
  • Hepatitis C elimination in France feasible if new infections in gay and bisexual men decline
  • HIV doubles the risk of liver fibrosis by middle age, without viral hepatitis
  • Launch of new international liver patients’ organisation: Liver Patients International
  • Catch up on the World Hepatitis Alliance webinar on hepatitis B diagnostics
  • Is this your copy of the infohep news bulletin?